Bioharvest Sciences Stock Five Year Return
| CNVCF Stock | USD 6.15 0.07 1.13% |
Bioharvest Sciences fundamentals help investors to digest information that contributes to Bioharvest Sciences' financial success or failures. It also enables traders to predict the movement of Bioharvest OTC Stock. The fundamental analysis module provides a way to measure Bioharvest Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bioharvest Sciences otc stock.
Bioharvest |
Bioharvest Sciences OTC Stock Five Year Return Analysis
Bioharvest Sciences' Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
According to the company disclosure, Bioharvest Sciences has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Bioharvest Fundamentals
| Return On Equity | -63.64 | |||
| Return On Asset | -0.53 | |||
| Profit Margin | (2.69) % | |||
| Operating Margin | (2.45) % | |||
| Current Valuation | 106.97 M | |||
| Shares Outstanding | 460.72 M | |||
| Shares Owned By Insiders | 35.15 % | |||
| Price To Book | 91.96 X | |||
| Price To Sales | 28.13 X | |||
| Revenue | 2.1 M | |||
| Gross Profit | 670 K | |||
| EBITDA | (8.63 M) | |||
| Net Income | (9.83 M) | |||
| Cash And Equivalents | 1.21 M | |||
| Total Debt | 3.97 M | |||
| Debt To Equity | 1.62 % | |||
| Current Ratio | 0.69 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (6.79 M) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 1.02 | |||
| Market Capitalization | 75.88 M | |||
| Total Asset | 10.21 M | |||
| Z Score | 11.4 | |||
| Net Asset | 10.21 M |
About Bioharvest Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bioharvest Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioharvest Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioharvest Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Bioharvest OTC Stock
Bioharvest Sciences financial ratios help investors to determine whether Bioharvest OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioharvest with respect to the benefits of owning Bioharvest Sciences security.